-
公开(公告)号:US20170151341A1
公开(公告)日:2017-06-01
申请号:US15356750
申请日:2016-11-21
Applicant: Pfizer Inc.
Inventor: Dangshe MA , Frank LOGANZO, JR. , Kimberly Ann MARQUETTE , Edmund Idris GRAZIANI , Puja SAPRA , Pavel STROP
Abstract: The present invention provides site specific HER2 antibody drug conjugates and methods for preparing and using the same.
-
公开(公告)号:US20200377615A1
公开(公告)日:2020-12-03
申请号:US16891460
申请日:2020-06-03
Applicant: Pfizer Inc.
Inventor: Dangshe MA , Frank LOGANZO, Jr. , Kimberly Ann MARQUETTE , Edmund Idris GRAZIANI , Puja SAPRA , Pavel STROP
Abstract: The present invention provides site specific HER2 antibody drug conjugates and methods for preparing and using the same.
-
公开(公告)号:US20200069764A1
公开(公告)日:2020-03-05
申请号:US16688173
申请日:2019-11-19
Applicant: Pfizer Inc.
Inventor: Dangshe MA , Kimberly Ann MARQUETTE , Edmund Idris GRAZIANI , Puja SAPRA , Lawrence Nathan TUMEY , Nadira Anarkali PRASHAD , Kiran Manohar KHANDKE , Eric M. BENNETT , Lioudmila TCHISTIAKOVA
Abstract: The invention relates to polypeptides, antibodies, and antigen-binding fragments thereof, that comprise a substituted cysteine for site-specific conjugation.
-
公开(公告)号:US20170216452A1
公开(公告)日:2017-08-03
申请号:US15356953
申请日:2016-11-21
Applicant: Pfizer Inc.
Inventor: Dangshe MA , Kimberly Ann MARQUETTE , Edmund Idris GRAZIANI , Puja SAPRA , Lawrence Nathan TUMEY , Nadira Anarkali PRASHAD , Kiran Manohar KHANDKE , Eric M. BENNETT , Lioudmila TCHISTIAKOVA
CPC classification number: A61K38/05 , A61K47/6803 , A61K47/6851 , A61K47/6855 , C07K16/283 , C07K16/32 , C07K2317/24 , C07K2317/52 , C07K2317/73 , C07K2317/732 , C07K2317/92 , C07K2317/94
Abstract: The invention relates to polypeptides, antibodies, and antigen-binding fragments thereof, that comprise a substituted cysteine for site-specific conjugation.
-
-
-